300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in Canada (October 2023)

The most active venture capital funds investing in Canada Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Canada Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Innovacorp
VC Fund
17 Canada, Australia, United States Seed, Grant Software, Information Technology, Health Care $25k–$3M
BDC Venture Capital
VC Fund
16 Canada, United States, Japan Series A, Seed Software, Information Technology, Internet $392k–$16M
Lumira Ventures
VC Fund
15 United States, Canada Series A, Series B Biotechnology, Health Care, Therapeutics $7M–$62M
Toronto Innovation Acceleration Partners
VC Fund
14 Canada, United States Pre-Seed, Seed Health Care, Biotechnology, Software $22k–$5.5M
Anges Quebec
VC Fund
14 Canada, Spain, United States Seed, Angel Health Care, Software, Artificial Intelligence $363k–$2.9M
Atlantic Canada Opportunities Agency
VC Fund
13 Canada, United States Debt Financing, Grant, Seed Software, Health Care, Information Technology $25k–$2.8M
MaRS Investment Accelerator Fund
VC Fund
11 Canada, United States Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $363k–$15M
Fonds de solidarité FTQ
VC Fund
10 Canada, United States, Israel Series A, Series B Manufacturing, Biotechnology, Software $2.2M–$38M
Real Ventures
VC Fund
10 Canada, United States Seed, Series A, Series B Software, Artificial Intelligence, Machine Learning $581k–$145M
FACIT
VC Fund
9 Canada, United States Seed, Pre-Seed Biotechnology, Health Care, Pharmaceutical $1M–$10M
E-Fund
VC Fund
9 Canada, China, United States Seed, Pre-Seed Health Care, Medical Device, Software $150k–$4.2M
Golden Ventures
VC Fund
8 Canada, United States, Japan Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.2M–$40M
Ontario Centres of Excellence
VC Fund
8 Canada, United States Seed, Grant, Pre-Seed Software, Information Technology, Health Care $11k–$2M
Amplitude Venture Capital
VC Fund
8 Canada, United States, Israel Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.9M–$85M
WUTIF
VC Fund
8 Canada Seed, Pre-Seed, Series A Health Care, Software, Biotechnology $77k–$2.7M
BoxOne Ventures
VC Fund
7 Canada, United States, Spain Seed, Series A, Pre-Seed Biotechnology, Health Care, Software $91k–$3.1M
MEDTEQ+
VC Fund
7 Canada Seed, Series A Health Care, Medical Device, Biotechnology $350k–$18M
VA Angels
VC Fund
7 Canada, United States, India Seed, Debt Financing Health Care, Software, Information Technology $109k–$1.5M
Cycle Capital
VC Fund
6 Canada, United States, Germany Series B, Seed Manufacturing, Energy, Electronics $54k–$20M
Business Development Bank of Canada
VC Fund
6 Canada, United States, Argentina Series A, Seed Software, Information Technology, Manufacturing $22k–$15M
Ramen Ventures
VC Fund
6 Canada, United States Seed, Pre-Seed, Angel Biotechnology, Health Care, Medical Device $120k–$3.2M
Genesys Capital
VC Fund
6 Canada, United States Series A, Series B Biotechnology, Health Care, Medical $1.8M–$38M
OrbiMed
VC Fund
6 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $10M–$120M
Hedgewood
VC Fund
5 Canada, United States, India Seed, Series A Health Care, Software, E-Commerce $500k–$11M
Sustainable Development Technology Canada
VC Fund
5 Canada, United States, Brazil Grant, Seed Energy, Manufacturing, Software $73k–$5.8M
Desjardins Venture Capital
VC Fund
5 Canada, United States Seed, Series A Software, Information Technology, Manufacturing $799k–$18M
National Research Council of Canada Industrial Research Assistance Program
VC Fund
5 Canada, Norway, Denmark Grant, Seed Biotechnology, Software, Health Care $25k–$2M
GreenSky Ventures
VC Fund
5 Canada, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $350k–$5.1M
GrowthWorks Capital
VC Fund
5 Canada, United States, Japan Series B, Series A Software, Biotechnology, Health Care $1.6M–$20M
CTI Life Sciences Fund
VC Fund
5 Canada, United States, France Series A, Series B, Seed Biotechnology, Therapeutics, Health Care $3.2M–$60M
Accelerate Fund
VC Fund
5 Canada, United States Series A, Seed Software, Information Technology, Health Care $91k–$12M
Garage Capital
VC Fund
5 Canada, United States, United Kingdom Seed, Series A, Pre-Seed Software, Information Technology, Internet $585k–$24M
Whitecap Venture Partners
VC Fund
5 Canada, United States Series A, Seed, Series B Health Care, Software, Enterprise Software $726k–$20M
Golden Triangle Angel Network
VC Fund
5 Canada, United States Seed, Angel, Grant Software, Health Care, Medical $10k–$2.4M
Groupe Roski
VC Fund
4 Canada, United States Seed, Series A Biotechnology, Health Care, Medical Device $1.5M–$20M
Apjohn ventures
VC Fund
4 United States, Canada Series A, Series C Health Care, Biotechnology, Life Science $2.5M–$39M
Maple Leaf Angels
VC Fund
4 Canada, United States Seed, Pre-Seed, Angel Health Care, Software, SaaS $90k–$2.5M
Angel Forum
VC Fund
4 Canada, United States Seed, Angel, Pre-Seed Biotechnology, Health Care, Software $20k–$500k
Horizons Ventures
VC Fund
4 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Artificial Intelligence, Software $750k–$70M
Viva BioInnovator
VC Fund
4 United States, Canada, Switzerland Seed, Series A, Series B Biotechnology, Health Care, Therapeutics $250k–$20M
Hike Ventures
VC Fund
4 United States, Canada, Israel Seed, Pre-Seed, Series A Artificial Intelligence, Software, Machine Learning $1M–$6M
Btomorrow Ventures
VC Fund
4 United States, United Kingdom, India Series A, Seed, Series B Health Care, Wellness, Food and Beverage $3.5M–$23M
Natacor Inc.
VC Fund
4 Canada, Australia Angel, Seed Biotechnology, Health Care, Medical Device $672k–$2.1M
Innovate Calgary
VC Fund
4 Canada, United States Seed, Pre-Seed Health Care, Medical, Medical Device $872k–$1.9M
Natural Products Canada
VC Fund
4 Canada Seed, Grant, Series A Biotechnology, Manufacturing, Food and Beverage $500k–$3.3M
OS Fund
VC Fund
4 United States, Canada Series A, Seed, Series B Biotechnology, Health Care, Health Diagnostics $1.6M–$220M
Radical Ventures
VC Fund
4 Canada, United States, United Kingdom Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $1.2M–$52M
INP Capital
VC Fund
4 Canada, United States, Australia Series A, Seed, Pre-Seed Health Care, Financial Services, Biotechnology $298k–$13M
1517 Fund
VC Fund
4 United States, Canada, India Seed, Pre-Seed, Series A Software, Internet, Health Care $100k–$15M
BDC Healthcare Venture
VC Fund
4 Canada Series B, Series A Biotechnology, Health Care, Therapeutics $4.7M–$68M
Access all 50 VC funds in Canada Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Innovacorp
VC Fund · Halifax, Nova Scotia, Canada · 17 investments in Canada Biotech startups

Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Grant
  • Geography: Canada, Australia, United States

Investor stats

  • Total investments: 139
  • Round size: Seed $50k–$3M; Grant $25k–$91k
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2016

Portfolio highlights

  • Bright Breaks — Bright offer on-site and virtual amenities for companies and employees. whether your team is on-site, working from home, or in between.
  • Gaia Refinery — Gaia is developing wind-driven methane-capture technology to produce rocket-grade natural gas.
  • Planetary — Planetary develops ocean-based carbon removal technology to accelerate the natural carbon cycle. Planetary’s system purifies the mountains of alkaline rock waste left behind by large-scale mining operations, extracting the alkalinity from the rubble and putting it in the ocean, thus accelerating the carbon transition and rebalancing oceanchemistry.Planetary Technologies is on a mission to remove 1 billion tonnes of carbon dioxide from the atmosphere by 2035.
Show all investments...

BDC Venture Capital
VC Fund · Calgary, Alberta, Canada · 16 investments in Canada Biotech startups, 33 in the past 12 months

BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strongCanadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises.BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Series A, Seed
  • Geography: Canada, United States, Japan

Investor stats

  • Total investments: 302
  • Round size: Seed $392k–$4M; Series A $2.5M–$16M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Cognota — Synapse helps companies around the world improve the productivity of their corporate learning and development teams. Our award-winning software streamlines training intake, project and capacity planning, and content design processes to make training teams more digital, agile, and efficient.This first-of-its-kind software allows our customers toget better visibility into the training needs of their businesses and consolidate the disparate tools they are using so they can access capacity data for better decision making and author course content with unprecedented speed.Collaboration with subject matter experts takes place directly within the platform ensuring knowledge is effectively captured and easy to update as required.The Synapse mission is to enable more people to learn and grow. Founded in 2015, Synapse has clients in multiple sectors and is based out of Toronto Canada with offices in San Diego and Merida, Mexico. For more information about Synapse software, visit www.getsynapse.com.
  • InnerSpace — InnerSpace is the fastest way to transform your business and power the hybrid workplace strategy. Transforming workplace experience with insights into how people use a space and create innovative solutions that drive revenue and improve operations to hybrid offices.
  • Carbon Upcycling — Carbon Upcycling Technologies (“CUT”) was formed to use the pollution of today to build the materials of tomorrow by converting CO2 gas into solid products. CUT sells advanced solid products derived from greenhouse emissions and cheaply available solids. Since 2014, CUT has scaled its ability to convert CO2 emissions into value-add end materials byover a million times. Through its portfolio of CO2-derived solid nanoparticles, CUT has technically validated its solutions for use in plastics, coatings, epoxy, adhesives, concrete, lithium-ion battery, and pharmaceutical industries. CUT recently launched a consumer brand called Expedition Air.CUT commercialized a corrosion-resistant coating, utilizing its nanoparticles, in 2017, becoming the youngest CO2 utilization company to generate commercial revenue (<2.5 years since inception) and has since been confirmed as one of the top CO2 utilization companies in the world as a winner of the X-Factor Award in the NRG COSIA Carbon XPRIZE. CUT has been named as a Solar Impulse Efficient Solution label recipient, a funding recipient of Fundación Repsol Entrepreneurs Fund, and a winner of the 2019 76West Clean Technology Competition.CUT’s most advanced product is its CO2-embedded concrete additive. In 2018, CUT graduated from the LafargeHolcim Accelerator in France and has continued conversations and testing with the company since then. CUT is also partnered with Burnco and Cemex. CUT’s commercial demonstration at the Alberta Carbon Conversion Technology Centre produces over 20 tonnes of concrete additives in a day. The product reduces the carbon footprint of concrete manufacturing by up to 25% while increasing the compressive strength of concrete by up to 40%.
Show all investments...

Lumira Ventures
VC Fund · Toronto, Ontario, Canada · 15 investments in Canada Biotech startups

Lumira Ventures, a later stage VC, partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 89
  • Round size: Series A $7M–$24M; Series B $12M–$62M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Deka Biosciences — Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.
  • Antiva Biosciences — Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego. They are now Antiva Biosciences which is headquartered in South San Francisco.
  • Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Show all investments...

Toronto Innovation Acceleration Partners
VC Fund · Toronto, Ontario, Canada · 14 investments in Canada Biotech startups

MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Pre-Seed, Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 56
  • Round size: Seed $60k–$5.5M; Pre-Seed $22k–$525k
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • PhenoTips — Imagine an Electronic Health Record designed for Genetics.
  • Damona Pharmaceuticals — Damona Pharmaceuticals is a pre-clinical pharmaceutical company treats and prevents cognitive deficits in a variety of brain disorders and during aging.
  • Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
Show all investments...

Anges Quebec
VC Fund · Quebec, Quebec, Canada · 14 investments in Canada Biotech startups, 6 in the past 12 months

Value-added investors for innovative entrepreneurs.

Show more...

Investment focus

  • Industry: Health Care, Software, Artificial Intelligence
  • Stage:Seed, Angel
  • Geography: Canada, Spain, United States

Investor stats

  • Total investments: 132
  • Round size: Seed $726k–$2.9M; Angel $363k–$1.1M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Bridgr — For industrial companies looking for significant digital transformation, BRIDGR is the algorithmic advisory practice that improves your odds of success by showing you what to do next and who would help
  • ChrysaLabs — Soil testing technology. ChrysaLabs provides real-time data for better decisions.
  • Ditch Labs — Ditch Labs is a digital health company pioneering nicotine addiction treatment with artificial intelligence and a revolutionary device.
Show all investments...

Atlantic Canada Opportunities Agency
VC Fund · Moncton, New Brunswick, Canada · 13 investments in Canada Biotech startups, 17 in the past 12 months

The Atlantic Canada Opportunities Agency works to create opportunities for economic growth in Atlantic Canada by helping businesses become more competitive, innovative and productive, by working with diverse communities to develop and diversify local economies, and by championing the strengths of Atlantic Canada. Together, with Atlantic Canadians,we are building a stronger economy.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Debt Financing, Grant, Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 104
  • Round size: Seed $25k–$2M; Grant $25k–$2.8M; Debt Financing $153k–$1M
  • Lead/follow: 65% lead, 35% follow

Portfolio highlights

  • Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
  • ReelData AI — ReelData AI provides artificially intelligent monitoring for finned fish aquaculture. It delivers weight distributions, feeding analysis, health analysis, and growth analysis
  • ABCO Industries — ABCO Industries manufactures metal products for the food, marine, industrial, and environmental industries. They are expanding and improving our manufacturing process, incorporating automated and advanced manufacturing techniques, and supporting our people through training and education.
Show all investments...

MaRS Investment Accelerator Fund
VC Fund · Toronto, Ontario, Canada · 11 investments in Canada Biotech startups

Working with Ontario talent to develop World Class Companies Learn More

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Canada, United States

Investor stats

  • Total investments: 139
  • Round size: Seed $363k–$3M; Pre-Seed $367k–$1M; Series A $6.8M–$15M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • ODAIA — Empowering Pharma's Next Generation of Engagement with HCPs
  • Vivid Machines — Digitizing permanent crop production | Vivid Machines | Ontario
  • InnerSpace — InnerSpace is the fastest way to transform your business and power the hybrid workplace strategy. Transforming workplace experience with insights into how people use a space and create innovative solutions that drive revenue and improve operations to hybrid offices.
Show all investments...

Fonds de solidarité FTQ
VC Fund · Montréal, Quebec, Canada · 10 investments in Canada Biotech startups, 8 in the past 12 months

Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession,financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Software
  • Stage:Series A, Series B
  • Geography: Canada, United States, Israel

Investor stats

  • Total investments: 164
  • Round size: Series A $2.2M–$38M; Series B $5.4M–$30M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • UgoWork — Lithium-ion batteries are significantly superior for your lift trucks, in addition to taking advantage of our efficient energy management. Learn more.
  • WorkJam — The most complete and modular suite of productivity tools for frontline employees. Trusted by global brands and loved by their employees.
  • Flare — We enable companies to prevent cyber attacks before they become costly data breaches.
Show all investments...

Real Ventures
VC Fund · Montréal, Quebec, Canada · 10 investments in Canada Biotech startups, 8 in the past 12 months

Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance,mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Canada, United States

Investor stats

  • Total investments: 195
  • Round size: Seed $581k–$4M; Series A $1.6M–$17M; Series B $7M–$145M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $131M in 2017

Portfolio highlights

  • dcbel — dcbel's mission is to deliver energy that lets people live a life without compromise.dcbel™ (formerly known as Ossiaco) sits at the nexus of residential solar power, electric vehicle charging, the smart home, and customer-centric utilities. The dcbel team has a proven history of rethinking energy distribution for everything from largeutility customers to distributed energy resource providers.dcbel's AI-driven sustainable technologies enable people to leverage solar energy to power their cars, their homes, and their lifestyles.dcbel has numerous worldwide patents in power electronics and power conversion and is backed by a number of globally respected investors.
  • HumanFirst — The complete productivity suite to transform natural language into business insights and AI training data
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
Show all investments...

FACIT
VC Fund · Toronto, Ontario, Canada · 9 investments in Canada Biotech startups

We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 24
  • Round size: Seed $1M–$10M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • QurCan Therapeutics Inc. — Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents(GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.
  • CTRL Therapeutics — CTRL Therapeutics is leading the new wave of biotechnology, unleashing the power of cell therapy for solid tumors in the fight to find treatments for all cancers.
  • Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
E-Fund
VC Fund · Vancouver, Alberta, Canada · 9 investments in Canada Biotech startups

The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Software
  • Stage:Seed, Pre-Seed
  • Geography: Canada, China, United States

Investor stats

  • Total investments: 52
  • Round size: Seed $150k–$4.2M; Pre-Seed $363k–$1M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Frontly — Frontly's no-code internal admin tooling platform empowers businesses to build custom applications to solve their greatest business challenges in minutes without writing a line of code.
  • Care2Talk — Care2Talk is a video call mobile app for senior citizens that is secure, fast, and easy to navigate with 7-day battery life.
  • VoxCell BioInnovation — Creating an extraordinary line of solutions for the drug development industry and the field of Oncology research.
Show all investments...

Golden Ventures
VC Fund · Toronto, Ontario, Canada · 8 investments in Canada Biotech startups, 8 in the past 12 months

Golden Ventures is a leading seed-stage venture capital fund, based in Toronto and investing across North America. We back bold teams and their transformative ideas.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Canada, United States, Japan

Investor stats

  • Total investments: 146
  • Round size: Seed $1.5M–$6M; Series A $3.5M–$32M; Series B $1.2M–$40M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • BenchSci — BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
  • Ideogram — Ideogram: Helping people become more creative.
  • Shakudo — Shakudo unites all of the data tools and services you need into a single comprehensive data platform, allowing your team to develop and deploy analytics-based solutions with ease.
Show all investments...

Ontario Centres of Excellence
VC Fund · Toronto, Ontario, Canada · 8 investments in Canada Biotech startups

The Ontario Centres of Excellence invests in projects and people to accelerate industry R&D to impact the Ontario economy through the commercialization of leading edge research.OCE invests in- Industry-Academic collaborative research- Commercialization of academic research through licensing and spin off companies- Early stage seedfinancing of start-ups- Skills development for high quality personnelThe Ontario Centres of Excellence is a not-for-profit corporation founded in 1987. Core funding is provided by the Ontario Ministry of Research and Innovation

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 145
  • Round size: Seed $38k–$2M; Grant $11k–$800k; Pre-Seed $38k–$1M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Uride — Welcome to Uride - your reliable and affordable ridesharing service with a community-focus. Enjoy the ease of quick pickups, lower fares, and a user-friendly app designed to make your travels smoother. Start riding today!
  • ventureLAB — At ventureLAB, we grow globally competitive tech titans that build-to-scale in Canada, for global markets.
  • Novel Biotechnology — Novel Biotechnology operates as a biotechnology company and develops innovative solutions for plasmid DNA production.
Show all investments...

Amplitude Venture Capital
VC Fund · Montréal, Quebec, Canada · 8 investments in Canada Biotech startups

We stand proudly on a foundation of deep experience and a demonstrable body of success creating, building, and growing break-out companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: Canada, United States, Israel

Investor stats

  • Total investments: 19
  • Round size: Seed $8M–$11M; Series A $2.9M–$85M; Series B $40M–$83M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $145M in 2019

Portfolio highlights

  • DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
Show all investments...

WUTIF
VC Fund · Vancouver, British Columbia, Canada · 8 investments in Canada Biotech startups

WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Canada

Investor stats

  • Total investments: 65
  • Round size: Seed $77k–$2.7M; Pre-Seed $363k–$1M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Frontly — Frontly's no-code internal admin tooling platform empowers businesses to build custom applications to solve their greatest business challenges in minutes without writing a line of code.
  • Care2Talk — Care2Talk is a video call mobile app for senior citizens that is secure, fast, and easy to navigate with 7-day battery life.
  • VoxCell BioInnovation — Creating an extraordinary line of solutions for the drug development industry and the field of Oncology research.
Show all investments...

BoxOne Ventures
VC Fund · Montréal, Quebec, Canada · 7 investments in Canada Biotech startups, 7 in the past 12 months

BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Canada, United States, Spain

Investor stats

  • Total investments: 39
  • Round size: Seed $91k–$3.1M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
  • Nimble Science — small intestine sampling technology - Nimble Science
  • Vivid Machines — Digitizing permanent crop production | Vivid Machines | Ontario
Show all investments...

MEDTEQ+
VC Fund · Montreal, Quebec, Canada · 7 investments in Canada Biotech startups

A voice in setting the standards, best practices and processes in health technologies ; a privileged access to 190+ members

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Series A
  • Geography: Canada

Investor stats

  • Total investments: 28
  • Round size: Seed $350k–$4M; Series A $2.9M–$18M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2018

Portfolio highlights

  • Eli — The women's health company providing lifelong insights from your saliva.
  • LUCID — LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness.
  • HALEO Clinic — HALEO is an online insomnia clinic that fits in your pocket
Show all investments...

VA Angels
VC Fund · Calgary, Alberta, Canada · 7 investments in Canada Biotech startups

VA Angels, one of Canada’s leading angel investment groups, has member locations in Calgary, Edmonton, Kelowna and Winnipeg. Since 2003 they have done 57 deals worth $28.5 million and are one of the most active angel groups in Canada.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Debt Financing
  • Geography: Canada, United States, India

Investor stats

  • Total investments: 104
  • Round size: Seed $109k–$1.5M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Tonit — Connect with local riders. Discover hundreds of rides & events. Track & share your ride. Share photos & videos with the community.
  • PLAYR.gg — Surf Giveaways is the #1 platform to run giveaways, sweepstakes, and contests for gamers. Grow your audience and build your community with giveaways now!
  • eThor — Trusted By National Brands Trusted By National Brands Contactless In the age of COVID-19, it's more important than ever to provide your customers a safe way to pay. eThor offers a number of contactless payment options, from Apple Pay, Samsung Pay or other forms of
Show all investments...

Cycle Capital
VC Fund · Montréal, Quebec, Canada · 6 investments in Canada Biotech startups

Cycle Capital is a pioneer in Canadian Cleantech venture capital fund management investing in companies at the development and commercialization stages in North America. Founded in 2009 by Andrée-Lise Méthot, Founder and Managing Partner, Cycle Capital’s Platform has become an important venture capital investor of the Cleantech industry with its 3funds totaling $230M Assets Under Management (AUM). Cycle Capital is looking to invests in promising ventures that are not capital intensive and/or that can benefit from the leverage brought by Cycle Capital extensive network of investors, strategic partners and advisors.In addition to its core investments, Cycle Capital targets companies with high growth potential – especially those with strong intellectual property, leading edge technologies and with exceptional management talent that would benefit from the firm’s network of strategic industrial partners and expert advisors. With its core investment and business expertise, Cycle Capital plays an active role adding meaningful and tangible value to its portfolio companies at all stages of their life.

Show more...

Investment focus

  • Industry: Manufacturing, Energy, Electronics
  • Stage:Series B, Seed
  • Geography: Canada, United States, Germany

Investor stats

  • Total investments: 67
  • Round size: Seed $54k–$2.7M; Series B $5.8M–$20M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $145M in 2020

Portfolio highlights

  • VueReal — VueReal is engineering the next electronic systems by mass integration of high-efficiency nano/micro-devices into large-area substrates (e.g., displays, sensors, system on panel, and more). They have started by making the true-life experience of micro-LED displays affordable for all applications (TV, laptop, smartphone,virtual/augmented reality, etc.). VueReal technology platform is based on the interplay of cutting-edge micro/nano-device processing, sophisticated integration technologies and advanced system design (hardware and software). VueReal technologies can enhance the experience of existing electronic systems and enable new applications by integrating millions of highly efficient micro-devices (micro-LED) into system substrate. As our Solid Printing (TM) technology works across all substrate sizes, it can develop displays ranging from super high ppi (>4000 ppi) to very large.
  • Airex Energy — Airex Energy provides solutions for a sustainable future. Helping reduce greenhouse gas emissions and remove carbon from the atmosphere.
  • SPARK Microsystems — Discover SPARK Ultra-wideband: Revolutionizing AR, VR, audio, gaming, and IoT with responsive low-latency, high-speed wireless transceivers.
Show all investments...

Business Development Bank of Canada
VC Fund · Montréal, Quebec, Canada · 6 investments in Canada Biotech startups, 19 in the past 12 months

We are BDC, the bank for Canadian entrepreneurs. We support small and medium-sized businesses in all industries and at every stage of growth with money and advice. We are the Business Development Bank of Canada.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Series A, Seed
  • Geography: Canada, United States, Argentina

Investor stats

  • Total investments: 207
  • Round size: Seed $22k–$4M; Series A $3M–$15M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • FlipGive — Free tools to simplify team money management and lower team fees. Earn cashback, balance the budget, accept fee payments, get a team spend card, and more.
  • Arolytics — Build, manage, and execute the most efficient emissions management program custom to your oil and gas operations.
  • Clear Blue Technologies — Clear Blue Technologies, the Smart Off-Grid company, combines green energy with the proven advantages of communications and cloud technology to power and control off-grid lighting, security and mobile solutions. We are ushering in a new age of off-grid systems, that deliver the reliability of grid connected systems but are environmentally friendly,less costly, and can be monitored and controlled over the Internet.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ramen Ventures
VC Fund · Toronto, Ontario, Canada · 6 investments in Canada Biotech startups

We angel invest in founders who will improve the lives of millions. Based in Toronto, Canada.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Canada, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $1.3M–$3.2M; Pre-Seed $120k–$800k
  • Lead/follow: 0% lead, 100% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2018

Portfolio highlights

  • Eli — The women's health company providing lifelong insights from your saliva.
  • Spare — Spare is on a mission to help accelerate the global shift to autonomous vehicles by enabling anyone to plan and launch a smart transportation network in seconds.Spare builds the tools that power the future of mobility services. From the world’s largest transportation companies to small rural transit agencies, our customers use Spare Platform tolaunch innovative and efficient transportation networks.
  • Mayday — Time is your most valuable asset. Make sure you're spending it wisely.
Show all investments...

Genesys Capital
VC Fund · Toronto, Ontario, Canada · 6 investments in Canada Biotech startups

Genesys Capital invests in and builds companies in the high-growth sectors of life sciences. We have a proven track record of identifying emerging bioscience opportunities, and transforming them into commercially successful companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Canada, United States

Investor stats

  • Total investments: 32
  • Round size: Series A $1.8M–$25M; Series B $20M–$38M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $125M in 2016

Portfolio highlights

  • Giiant Pharma — Giiant is a preclinical-stage biotech company that, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerabilityand enhanced therapeutic effect.
  • Inversago Pharma — Inversago Pharma is a preclinical-stage, biotech company specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists.
  • Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 6 investments in Canada Biotech startups, 38 in the past 12 months

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 419
  • Round size: Series A $10M–$102M; Series B $23M–$120M; Series C $12M–$108M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
  • Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
  • Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
Show all investments...

Hedgewood
VC Fund · Toronto, Ontario, Canada · 5 investments in Canada Biotech startups

Hedgewood is an investment firm active in venture capital, internet businesses, real estate, specialty finance, asset management, and private equity.

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Series A
  • Geography: Canada, United States, India

Investor stats

  • Total investments: 109
  • Round size: Seed $500k–$4.3M; Series A $7M–$11M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Unito — Connect the tools you're already using with deep 2-way integrations and optimize workflows for Asana, Jira, Trello, Google Sheets and more.
  • Vetster — Pet health starts with Vetster. Find and book veterinarians from across North America to provide excellent health care for your pet through video consults. Cats, dogs, reptiles, horses - all pets are welcome.
  • Ready, Set, Food! — Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system.
Show all investments...

Sustainable Development Technology Canada
VC Fund · Ottawa, Ontario, Canada · 5 investments in Canada Biotech startups, 8 in the past 12 months

At Sustainable Development Technology Canada (SDTC), they fund Canadian cleantech projects and coach the companies that lead them as they move their ground-breaking technologies to market.SDTC’s support of cleantech translates into jobs, growth, and export opportunities for Canadian companies, as well as economic, environmental and healthbenefits for all Canadians. They are independent but don’t work alone. A big part of their role is building and sustaining networks of partners and stakeholders from private industry, academia and governments, at home and abroad. They operate at arm’s length and receive funding from the Government of Canada.

Show more...

Investment focus

  • Industry: Energy, Manufacturing, Software
  • Stage:Grant, Seed
  • Geography: Canada, United States, Brazil

Investor stats

  • Total investments: 160
  • Round size: Seed $73k–$1.7M; Grant $872k–$5.8M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • Niricson — Niricson Software has developed a proprietary damage assessment software platform paired with a patent-pending drone-based data collection technology that helps infrastructure owners inspect their structures (e.g. hydro dams) in a way that is more accurate, five times faster, and 50% more cost-effective. Niricson is differentiated by its ability toautomatically detect and quantify not only surface damage, but also subsurface damage.
  • ZeroIN — For ingredient manufacturers seeking to enhance the taste profile of their sweeteners, ZeroIN develops technology to produce next-gen sweeteners with the same bulk, sweetness, and taste as sugar but no aftertaste.
  • Cyclic Materials — Cyclic Materials has created the first circular supply chain for rare earth elements with the goal of helping the world transition to an environmentally responsible future.
Show all investments...

Desjardins Venture Capital
VC Fund · Lévis, Quebec, Canada · 5 investments in Canada Biotech startups

Desjardins Capital makes it easy to grow your business with financial and strategic support. Investment capital and venture capital can help you meet your business goals.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Canada, United States

Investor stats

  • Total investments: 126
  • Round size: Seed $799k–$5.2M; Series A $4.7M–$18M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Cegerco — Cegerco specializes in the construction of industrial and institutional sectors. They also restore and renovate historic buildings, while maintaining the original materials. They provide services in the mining sector like silos, conveyors, crushers, etc.
  • Groupe Canva — Canva Group is a dynamic holding company in the identification and visual communications field with 9 complementary companies acquired over the last 15 years. Operating with 3 different autonomous business units under the names of Idenco Canada (Boucherville), Decalcomanie Artistic (Montreal) and Mirazed in (St-Hubert), the 200-employee companyserves more than 4,000 customers with its complementary serigraphy and digital printing services. Their goal is to create the best customer experience.
  • Voilà! Technologies — Learn how Evolia's employee scheduling app can save you time managing schedules and increase employee engagement.
Show all investments...

National Research Council of Canada Industrial Research Assistance Program
VC Fund · Ottawa, Ontario, Canada · 5 investments in Canada Biotech startups

National Research Council of Canada Industrial Research Assistance Program

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: Canada, Norway, Denmark

Investor stats

  • Total investments: 108
  • Round size: Seed $25k–$2M; Grant $36k–$1.5M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Levr.ai — Levr.ai is an intelligent loans platform built to get your business funded—fast
  • Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
  • Connektica — Connektica offers its innovative radiofrequency testing solutions to reduce cost while maintaining quality standards.
Show all investments...

GreenSky Ventures
VC Fund · Toronto, Ontario, Canada · 5 investments in Canada Biotech startups

GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies.GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSkyAccelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs.GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 44
  • Round size: Seed $350k–$5.1M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Direct-C — Remote asset monitoring systems for oil and gas infrastructure that provide rapid leak detection for liquid hydrocarons, produced water and more.
  • Captain AI — Captain is the leading delivery management software for restaurant chains. Gain true visibility into your delivery operations while automating dispatch decisions and optimizing delivery times.
  • Mission Control Space Services Inc. — Mission Control is a space exploration and robotics company specializing in spacecraft operations, onboard autonomy and artificial intelligence. We are developing a full-stack robotic control solution. Our technology is designed to control and automate robotic assets operating in harsh and remote environments and increase the safety, efficiency andscientific or financial return of missions.
Show all investments...

GrowthWorks Capital
VC Fund · Vancouver, British Columbia, Canada · 5 investments in Canada Biotech startups

Invest in our experienceGrowthWorks* offers you more: more accountability, more experience and more proven know-how to make the most of your investment.A principled approach to adding valueOver the last 20 years, we've built GrowthWorks into one of Canada's venture capital management companies. We've done that by managingfunds that rigorously follow core principles: structure strategic investments in growth-oriented companies, value portfolio assets conservatively, build vital industry connections and minimize risk through diversification. It's a simple formula that delivers powerful results.Regional know-how. National ReachAt GrowthWorks, we offer regionally based retail venture capital funds (RVCs) right across Canada.GrowthWorks specializes in the management of and growth of regionally based venture capital funds. The funds under management include the following RVCs: Working Opportunity Fund, GrowthWorks Commercialization Fund and GrowthWorks Atlantic Venture Fund.Partners in performanceWe have specialized teams in each of our core sectors to identify and structure investments in potential winners. These skilled teams also help create success by helping the companies that GrowthWorks managed funds invest in to grow with strategic management support and advice. This way, the companies get guidance from experienced leaders. In turn, the funds’ investors know that these companies receive direction to help them thrive.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series B, Series A
  • Geography: Canada, United States, Japan

Investor stats

  • Total investments: 113
  • Round size: Series A $1.6M–$20M; Series B $2.7M–$20M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — last raise in 2006

Portfolio highlights

  • ClearRisk — Our easy-to-use risk management software increases productivity, creates differentiation, and adds a simple and efficient process to manage risk!
  • HIGHLINEvc — HIGHLINE is a Pre-Seed investor & Acceleration Platform that helps digital startups get follow-on capital, backed by leading VCs with offices in Vancouver & Toronto.We believe in providing our founders with far more than capital. Yet unlike most accelerators, we have no rigid start/end dates throughout the year. By joining theHIGHLINE family, you get to call on us for advice on an ongoing basis, gain access to our premium network and monthly founder events. We’ll do our best to help with fundraising challenges and partner with incubators to help deliver specialized programming.
  • SWITCH Materials — SWITCH Materials develops revolutionary new materials based on proprietary organic molecules that "switch" optical properties on command.SWITCH’s molecular switches can be developed for a number of applications, especially in the areas of molecular electronics and health sciences, including optical filters, photochromic inks, paintsand fibers, high-density optical information storage systems, molecular sensors and biomarkers for labeling and tracking of live cells.SWITCH has assembled a team of cutting-edge materials scientists with combined expertise in synthetic chemistry, polymer processing, optics, and molecular & materials engineering. SWITCH conducts its research and development activities in our own laboratories and the state-of-the-art analytical and clean room facilities at 4D LABS, Simon Fraser University's new $40 million materials science research centre.
Show all investments...

CTI Life Sciences Fund
VC Fund · Montréal, Quebec, Canada · 5 investments in Canada Biotech startups

CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $345 million of assets.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: Canada, United States, France

Investor stats

  • Total investments: 15
  • Round size: Seed $3.2M–$13M; Series B $29M–$60M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Epitopea — Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. Cryptigen™ TSAs are discovered by a proprietary approach deploying immunopetidomics, mass spectrometry, genomics, andbioinformatics, which allows the identification of conserved, aberrantly-expressed, tumour-specific antigens, hidden in cancer's 'junk' DNA. These hidden Cryptigen™ TSAs have been identified by research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal.
  • Phenomic AI — Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.The company's platform uses artificial intelligence to analyze phenotypes in complex disease models including high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs in aneasier way.
  • Domain Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Accelerate Fund
VC Fund · Calgary, Alberta, Canada · 5 investments in Canada Biotech startups

Accelerate Fund supports the growth of early-stage Alberta technology companies with a multi million dollar fund that combines co-investment from angel investors.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 46
  • Round size: Seed $91k–$2.8M; Series A $944k–$12M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $15M in 2020

Portfolio highlights

  • Areto Labs — Areto Labs is a human-focused cyber security company that uses AI to protect people by detecting and counteracting online abuse.
  • PayShepherd — PayShepherd helps manage contractor billing for industrial facilities and simplifies billing processes. Save time, money, and headaches.
  • Truffle — Truffle enables restaurants of all sizes to empower their teams, increase profits, and provide a smart dining experience that customers expect, with tools to manage your restaurant in a single platform. Truffle offers restaurants flexible tools to expand into Point of Sale, Online Ordering, Table Side, Delivery Management, Automated Pickup, TableReservations and Guest Marketing.
Show all investments...

Garage Capital
VC Fund · Waterloo, Ontario, Canada · 5 investments in Canada Biotech startups, 10 in the past 12 months

Built by founders, for founders. Garage Capital helps best-in-class companies jump from garage to growth.

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $2M–$6.5M; Pre-Seed $585k–$3.6M; Series A $7.3M–$24M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Eli — The women's health company providing lifelong insights from your saliva.
  • Quilt — Quilt's mission is to move humanity off fossil fuel heating, starting with the home. 20% of US global warming emissions come from homes (that’s more than cars!). The largest driver of home emissions is burning fossil fuels for heat. Quilt's first product is a next generation heating and cooling system that makes homes more comfortable,healthier and more efficient, based on all-electric heat pump technology.
  • Finta — Finta lets founders and operators easily manage taxes, bookkeeping, and financial insights - all in one platform.
Show all investments...

Whitecap Venture Partners
VC Fund · Toronto, Ontario, Canada · 5 investments in Canada Biotech startups

Whitecap Venture Partners is a Canadian-based Venture Capital fund investing in early stage technology companies. Whitecap is headquartered in Toronto and invests across Canada and the Northeastern US. Since Whitecap’s inception the early 1990s, Whitecap recognises the power of real collaboration between entrepreneurs and investors. This rapportenables them to provide significant value to companies along with strong returns across investment cycles.Whitecap specialises in Information & Communication Technologies (ICT) and Medical Technologies. Whitecap is continually searching for upcoming ventures to support as the next generation of exceptional enterprises.

Show more...

Investment focus

  • Industry: Health Care, Software, Enterprise Software
  • Stage:Series A, Seed, Series B
  • Geography: Canada, United States

Investor stats

  • Total investments: 39
  • Round size: Seed $726k–$6M; Series A $4.7M–$17M; Series B $8.3M–$20M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Altrio — Altrio is bringing real estate capital markets online
  • Mash — The internet is fundamentally broken. It's because of monetization. “Show me the incentives and I'll show you the outcome.”Our mission is to remonetize the web by enabling value for value monetary exchanges between pubs/creators/orgs and their users. A new business model for the open internet.We are unlocking this withfriction-minimized streaming payments that are no/low cost, instantly settled, trust-minimized.It is built on the best global digital monetary network ever conceived, Bitcoin. Enabled by Lightning Network. Most users don't need to know this or be a Bitcoiner. Over time we suspect many will.
  • InvestNext — Create sharable offering pages, collect digital signatures, and pay your investors automatically.
Show all investments...

Golden Triangle Angel Network
VC Fund · Cambridge, Ontario, Canada · 5 investments in Canada Biotech startups

The Golden Triangle Angelnet is a not-for-profit corporation operating under the Ontario Ministry of Research and Innovation's Angel Network Program. It is a members-only organization comprised of Angel investors seeking investment opportunities in promising, early-stage businesses. In addition to the financial support, as part of theirall-encompassing commitment to assist the companies they invest in, its Angels often provide valuable mentorship and access to strong relationship capital networks to their investee companies. It is this priceless assistance that aids in the facilitation of learning, networking, and growth.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Angel, Grant
  • Geography: Canada, United States

Investor stats

  • Total investments: 29
  • Round size: Seed $10k–$2.4M; Angel $500k–$672k
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Justo — Call Toronto real estate brokerage, agents and MLS listings provider - Justo to sell or buy houses or condos in Greater Toronto Area.
  • LabsCubed — LabsCubed manufactures automated multi-sample tensile testing robots that manufacturers use to increase lab efficiency and reduce labor by up to 85%.
  • Motion Gestures — Motion Gestures is a Canadian machine learning startup specializing in gesture recognition software. Motion Gestures specializes in machine learning-based gesture recognition software and was founded in Waterloo, Canada in 2016. The company aims to enable the rapid development and deployment of gesture-enabled interfaces for systems, devices, andapps. Its software supports advanced 2D and 3D gestures using motion, touch, and vision sensors and can be deployed on the cloud, gateway/hub, and embedded platforms. Developers are offered free licenses to the cloud SDK and can quickly create and test any gesture using their smartphones.
Show all investments...

Groupe Roski
VC Fund · Montréal, Quebec, Canada · 4 investments in Canada Biotech startups

Groupe Roski is a private investment company that has been involved in venture capital since 2013 with companies that improve the quality of life and the environment for individuals.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Seed, Series A
  • Geography: Canada, United States

Investor stats

  • Total investments: 14
  • Round size: Seed $1.5M–$3.9M; Series A $14M–$20M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Spiderwort — Spiderwort is an innovator in all-natural, plant-based biomaterials that have the potential to repair spinal cord injuries and promote healing.
  • Groupe Evex — Groupe Evex deals with the commercial real estate projects.
  • Marmax — Marmax deals with residential and commercial construction, renovation and roofing.
Show all investments...

Apjohn ventures
VC Fund · Kalamazoo, Michigan, United States · 4 investments in Canada Biotech startups

Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstandinggrowth potential.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Series A, Series C
  • Geography: United States, Canada

Investor stats

  • Total investments: 15
  • Round size: Series A $2.5M–$39M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Tetra Discovery — Leaders in innovative memory loss treatments. Developing drugs to treat Alzheimer's, Depression, and Brain Injury.
  • Tetra Therapeutics — Leaders in innovative memory loss treatments. Developing drugs to treat Alzheimer's, Depression, and Brain Injury.
  • Sierra Oncology — Sierra Oncology is late-stage clinical drug development biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer.
Show all investments...

Maple Leaf Angels
VC Fund · Toronto, Ontario, Canada · 4 investments in Canada Biotech startups

Maple Leaf Angels are an experienced group of private investors looking for great entrepreneurs, great products and great companies. Bringing together investment, experience and knowledge, we help accelerate companies to become market leaders in their industry.We focus on four main investment areas as follows:- Information Technology- CleanTechnology- Advanced Manufacturing and Materials- Special Opportunities

Show more...

Investment focus

  • Industry: Health Care, Software, SaaS
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Canada, United States

Investor stats

  • Total investments: 39
  • Round size: Seed $438k–$2.5M; Pre-Seed $90k–$1M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Grüvi — Gruvi is a line of craft brewed alcohol-free beers & wines.
  • Wyvern — Wyvern was created to unlock the secrets of the elec-tromagnetic spectrum by providing groundbreak-ing access to high-resolution and quality imagery.This will enable a sustainable future for humanity.
  • EmergConnect — Emergconnect is creating the first ever digital 'front door' for patients seeking same day care.
Show all investments...

Angel Forum
VC Fund · Vancouver, British Columbia, Canada · 4 investments in Canada Biotech startups

Founded 16 years ago in 1997, it is the only Angel Capital Forum ™ in Canada that introduces emerging companies to private equity Angel Investors. Presenting companies have raised over $35 million directly through the Forum. Read this third party blog comment and video overview. Since 1998, it has offered Investor Ready ™ workshops for companies& investors.As the oldest & largest angel network in Western Canada with 50+ investors (from Vancouver, Calgary, Edmonton, Kelowna, Victoria, Bellingham and Seattle), they are supported by leading organizations in BC and belong to Canada's National Angel Capital Organization and US's Angel Capital Association. Their private meetings are exclusive to only pre-registered Investors, selected Companies and Sponsors. Regretfully no observers except volunteers.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $20k–$500k
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Cuboh — Cuboh consolidates all your food delivery orders in one tablet and integrates them with your restaurant's POS system. Cuboh, online ordering on autopilot.
  • MazumaGo — Send and receive business payments online with no limits, no percentage fees and no bullsh*t. Bring your business payments into the 21st century.
  • Orbitless Drive — ORBITLESS™ is the first novel drivetrain technology in generations. The patent pending ORBITLESS™ Drive can be used in a variety of applications from Motion Control, Robotics, Electric vehicles, Wind Power or really anywhere gear motors are used . It can be an alternative to a Planetary Drives, Harmonic (strain-wave) or Spur Gearsets, or used incombination to derive the desired ideal gearbox. Available in single stage, multi-stage, high and low ratio configurations, the possibilities are endless. We work with leading innovative gearhead, power transmission, and gearmotor companies that are looking to maintain their competitive edge. Our company provides a technical consultancy service and a support network, to offer external clients transmission design, analysis, build and test engineering.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 4 investments in Canada Biotech startups, 17 in the past 12 months

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 216
  • Round size: Seed $750k–$11M; Series A $6M–$30M; Series B $8M–$70M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
  • Erthos — erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
  • ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Show all investments...

Viva BioInnovator
VC Fund · Shanghai, Shanghai, China · 4 investments in Canada Biotech startups

Viva BioInnovator (VBI) is the specialized investment and incubation arm of Viva Biotech Holdings. We focus on the initial creation and development of biotech startups across all indications and drug types. During the early stages of drug discovery, we can nurture and accelerate a startup's growth from idea to clinical program. VBI'sunique investment and incubation model started out of necessity in 2014. Our roots are in drug discovery services, where we operate world-leading and proprietary drug discovery platforms. While serving big pharma customers from around the globe, we came to realize the huge demand from many entrepreneurs who have great ideas but cannot receive funding to advance their plan due to lack of data. We saw the value in many of these innovative ideas and provided our CRO drug discovery services, operational support, and monetary backing to help these creative scientists embark on the "0 to 1"​ transformation. This spark launched our "equity for service (EFS)"​ investment and incubation model. VBI is based in Shanghai, with an office in Boston and personnel in California. As of early 2019, VBI has invested in over 30 companies out of the hundreds of proposals submitted for review and we plan to invest at a rapid pace in the years to come. The majority of our current portfolio companies are US based, but we are open to proposals globally and are excited to see new ideas that fit our investment strategy. If you would like to learn more about us, please visit: www.vivabioinnovator.com Or send an email to innovation@vivabiotech.com If you would like to learn more about our parent company, Viva Biotech, please visit: www.vivabiotech.com

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Switzerland

Investor stats

  • Total investments: 23
  • Round size: Seed $1M–$9.5M; Series A $250k–$20M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
  • Deka Biosciences — Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Hike Ventures
VC Fund · San Francisco, California, United States · 4 investments in Canada Biotech startups

Hike Ventures is a venture capital firm that invests in artificial intelligence and machine learning.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 37
  • Round size: Seed $1.1M–$6M; Pre-Seed $1M–$1M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • BurnBot — Burnbot is a tech forward provider of wildfire mitigation, vegetation management, and prescribed fire operations. We offer force-multiplying solutions that reduce the risk of wildfire damage for critical infrastructure, firefighting agencies, agriculture, private enterprise, public lands, conservati
  • NExTNet — NExTNet is a Silicon Valley Venture-backed Generative AI technology startup. Our mission is to organize and integrate the world’s biomedical knowledge and make it accessible.
  • Mesh — Mesh enables safer, easier crypto transfers and payments from 300+ leading exchanges and wallets, all without leaving your platform
Show all investments...

Btomorrow Ventures
VC Fund · London, England, United Kingdom · 4 investments in Canada Biotech startups, 6 in the past 12 months

Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 44
  • Round size: Series A $3.5M–$23M
  • Lead/follow: 76% lead, 24% follow

Portfolio highlights

  • Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
  • Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
  • PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Show all investments...

Natacor Inc.
VC Fund · Ottawa, Ontario, Canada · 4 investments in Canada Biotech startups

Natacor Inc. is a firm that provides financial and business advising as well as capital investments.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Angel, Seed
  • Geography: Canada, Australia

Investor stats

  • Total investments: 10
  • Round size: Angel $672k–$2.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Viafoura — We partnered with 800+ media brands to engage, convert & monetize their digital audiences. Check out our community engagement solutions!
  • Nicoya Lifesciences — World's first personal surface plasmon resonance instruments designed for the individual researcher at the comfort of their own bench.
  • Vida Fresh Air — Vita Fresh Air Corp has developed and is set to commercialize a new catalytic converter technology, the Multi-Chamber Catalytic Converter (MCCC), which aims to lower emissions, lower fuel consumption, and lower equipment costs. Vida’s mission is to develop automotive products that genuinely improve engine performance and emission control in anethical, economical and sustainable manner.
Show all investments...

Innovate Calgary
VC Fund · Calgary, Alberta, Canada · 4 investments in Canada Biotech startups

Innovate Calgary is a central innovation hub at the University of Calgary. See our programs and fundings and learn more about our innovation hubs here.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 36
  • Round size: Seed $872k–$1.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • MACH32 — MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
  • InventoRR MD — InventoRR MD focuses on commercializing groundbreaking trauma and general surgery devices that improve patient recovery outcomes, simplify procedures for doctors, and reduce costs for healthcare organizations.
  • Difinity Solutions — Difinity Solutions is specializing in the development of medical devices and technology solutions.
Show all investments...

Natural Products Canada
VC Fund · Charlottetown, Prince Edward Island, Canada · 4 investments in Canada Biotech startups

Natural Products Canada provides insight, introduction, and investment to help entrepreneurs, corporations, and investors leverage the growing demand for naturally-derived products. It connects industry, investors, researchers, and others to help innovative natural products reach their full potential in the market. The company works with smallcompanies, large and multinational corporations, research institutions, investors, innovation and economic development agencies, and business, and commercialization experts such as IP, marketing, and regulatory consultants. Collaborating with these many stakeholders, the company evaluates products and technologies, helps companies overcome commercialization hurdles, and invest in the opportunities that show the most promise.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Food and Beverage
  • Stage:Seed, Grant, Series A
  • Geography: Canada

Investor stats

  • Total investments: 11
  • Round size: Seed $500k–$3.3M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
  • Partake Brewing — Partake Brewing is the craft non-alcoholic beer brand that focuses on flavor, health, socializing, and inclusivity for people who choose not to drink alcohol whether as a need or increasingly as a lifestyle choice.
  • Impactful Health R&D — Impactful Health R&D is a developer of compostable active packaging materials designed to prolong the shelf life of fresh foods, starting with fresh fish as an entry market. The company's active packaging materials are made of naturally-derived resources and helps in preserving the texture of a fish by maintaining its water content andtargeting bacteria, enabling fish processing companies to reduce wastage of fish.
Show all investments...

OS Fund
VC Fund · Park Ridge, Illinois, United States · 4 investments in Canada Biotech startups

We partner with future literate entrepreneurs who understand our unique time and place in history, with the ambition to author a better future for humanity.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Health Diagnostics
  • Stage:Series A, Seed, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 48
  • Round size: Seed $1.6M–$6M; Series A $4.5M–$13M; Series B $7.5M–$220M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Arzeda — Arzeda develops enzyme design technology that presents a new way of thinking about biocatalysis. The company was founded by David Baker and three senior members of his lab to commercialize and further develop its computational enzyme design technology.
  • A-Alpha Bio — Measure more protein interactions
  • Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.
Show all investments...

Radical Ventures
VC Fund · Toronto, Ontario, Canada · 4 investments in Canada Biotech startups, 12 in the past 12 months

Radical Ventures is an early-stage venture capital firm investing in entrepreneurs applying deep technology to transform massive industries.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 66
  • Round size: Seed $1.2M–$5M; Series A $6.5M–$52M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Reka AI — Reka is an AI research and product company that develops models to benefit humanity and advance the state-of-the-art.
  • Pixxel — Pixxel is a space technology startup that builds a constellation of advanced hyperspectral earth imaging small satellites. By capturing images in a 100s of hyperspectral bands, Pixxel is able to see things in 50x richer detail enabling organisations around the world to make better business discussions. Pixxel is leveraging the unique hyperspectralnature of satellite imagery to build a health monitor for the planet.
  • Genesis Therapeutics — Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction.The company was founded in 2019and based in South San Francisco, California.
Show all investments...

INP Capital
VC Fund · Vancouver, British Columbia, Canada · 4 investments in Canada Biotech startups

INP Capital is a global private-market investor with international offices in Canada, Australia, China, UK and Germany. We back and invest in entrepreneurs looking to change the world. We are committed to building long-term relationships with our investors, investment partners and colleagues.

Show more...

Investment focus

  • Industry: Health Care, Financial Services, Biotechnology
  • Stage:Series A, Seed, Pre-Seed
  • Geography: Canada, United States, Australia

Investor stats

  • Total investments: 26
  • Round size: Seed $2M–$2.3M; Pre-Seed $298k–$875k; Series A $5M–$13M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Samsara Eco — Samsara Eco is an enviro-tech company creating infinite recycling to end plastic pollution.
  • COVU — COVU delivers AI-driven technology to empower Insurance agencies and their customers.
  • Genecis — Genecis proprietary technology utilizes bacteria to convert food waste into PHA plastic, a biodegradable alternative to traditional plastics
Show all investments...

1517 Fund
VC Fund · San Francisco, California, United States · 4 investments in Canada Biotech startups, 13 in the past 12 months

1517 Fund is an early stage venture capital fund that supports teams led by dropouts, deep-tech scientists & founders working outside of tracked institutions.

Show more...

Investment focus

  • Industry: Software, Internet, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 90
  • Round size: Seed $600k–$10M; Pre-Seed $100k–$1.4M; Series A $5.5M–$15M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2019

Portfolio highlights

  • Sinatra — Sinatra is a technology company that, with its all-in-one app, aims to revolutionize the hospitality industry. It provides Sinatra Training, which enables continuous digital training for employees by allowing employers to upload content and employees to access it via the app.
  • H2Ok Innovations — H2Ok Innovations Harnesses Artificial Inteligence and Data Science to Empower Comunities With the Knowledge for Clean Water.
  • Optimotive — Optimotive builds robotic platforms as a service for hazardous, laborious, or otherwise extreme environments.
Show all investments...

BDC Healthcare Venture
VC Fund · Montréal, Quebec, Canada · 4 investments in Canada Biotech startups

BDC Healthcare Venture is a venture capital firm specializes in healthcare investments. The firm prefers to invest in the innovative therapeutics, medical technology, health technology, prevention, diagnostics, personalized treatment, mobile technologies and services, robotics, automation and disease management sectors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A
  • Geography: Canada

Investor stats

  • Total investments: 13
  • Round size: Series A $8M–$68M; Series B $4.7M–$17M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Xagenic — Xagenic Inc., a Toronto, Canada-based molecular diagnostics company developing new technology for decentralized, rapid diagnostic testing, and a true point-of-care platform. Our aim is to enable on-demand, near-patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of the first consultation.This will dramatically improve patient care and reduce health care costs. Xagenic has adapted this technology to permit rapid, enzyme-free detection of nucleic acids from clinical samples.We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
  • Repare Therapeutics — Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines.
  • PHEMI — NSA-grade privacy, security, governance, and data management system for Azure. Control access to health data at scale.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Canada Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists